| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | PFE Pfizer Inc | Dolsten Mikael56 | President R&D | Sell | 63,902 | $49.32 | $3,151,547.14 | -2.7% | +2.3% | -22.1% | |
| May 10, 2022 | LNTH Lantheus Holdings, Inc. | Ber Gerard | Director | Sell | 1,277 | $58.19 | $74,308.63 | -3.8% | +36.1% | +70.1% | |
| May 10, 2022 | ALKS Alkermes Plc. | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $27.22 | $680,380.00 | -9.7% | -4.5% | +16.4% | |
| May 9, 2022 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 12,276 | $61.19 | $751,119.83 | -0.3% | +42.6% | +75.2% | |
| May 9, 2022 | PCRX Pacira Biosciences, Inc. | Froimson Mark72 | Director | Sell | 1,000 | $59.37 | $59,370.00 | -16.9% | -1.7% | -28.3% | |
| May 9, 2022 | NBIX Neurocrine Biosciences Inc | Pops Richard F57 | Director | Sell | 15,000 | $76.30 | $1,144,462.50 | -20.3% | +38.0% | +28.3% | |
| May 6, 2022 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 30,000 | $0.19 | $5,724.00 | -0.1% | - | - | |
| May 6, 2022 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 347,257 | $27.98 | $9,717,783.63 | -10.8% | -6.3% | +6.6% | |
| May 5, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $190.65 | $1,143,893.52 | -3.8% | +22.2% | +14.5% | |
| May 3, 2022 | ALKS Alkermes Plc. | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $28.62 | $715,415.00 | -9.7% | -13.2% | -1.2% | |
| May 2, 2022 | ALKS Alkermes Plc. | Cooke Shane62 | Director | Sell | 10,000 | $29.23 | $292,330.00 | -10.0% | -12.8% | -1.3% | |
| May 2, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 295 | $35.18 | $10,378.30 | -0.2% | +4.8% | +4.6% | |
| Apr 29, 2022 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 641 | $2.61 | $1,673.11 | +0.1% | -3.4% | -27.2% | |
| Apr 29, 2022 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 1,069 | $2.61 | $2,791.01 | - | -3.4% | -27.2% | |
| Apr 29, 2022 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 318 | $2.61 | $830.30 | +0.1% | -3.4% | -27.2% | |
| Apr 29, 2022 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 214 | $2.61 | $558.95 | +0.1% | -3.4% | -27.2% | |
| Apr 26, 2022 | SCYX Scynexis Inc | Sukenick Scott | General Counsel | Buy | 3,500 | $3.00 | $10,500.00 | +7.0% | -6.5% | +30.4% | |
| Apr 26, 2022 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 2,167 | $178.96 | $387,806.32 | -8.4% | -0.8% | -1.9% | |
| Apr 26, 2022 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 75,000 | $3.00 | $225,000.00 | +38.1% | -6.5% | +30.4% | |
| Apr 26, 2022 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 20,000 | $0.21 | $4,224.00 | - | - | - | |
| Apr 25, 2022 | ALKS Alkermes Plc. | Cooke Shane62 | Director | Sell | 10,000 | $27.88 | $278,849.00 | -10.0% | +2.0% | +7.2% | |
| Apr 25, 2022 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 15,000 | $92.76 | $1,391,392.50 | -6.7% | +1.6% | +9.2% | |
| Apr 21, 2022 | JNJ Johnson & Johnson | Hait William65 | See Remarks | Sell | 29,699 | $183.58 | $5,452,053.32 | -3.4% | -6.3% | -9.5% | |
| Apr 21, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $189.18 | $1,135,077.73 | -4.8% | +18.9% | +21.3% | |
| Apr 21, 2022 | PCRX Pacira Biosciences, Inc. | Reinhardt Max79 | President, Rest Of World | Sell | 9,824 | $73.25 | $719,647.30 | -24.9% | -30.2% | -37.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.